ALUMIS INC. (ALMS)
ALUMIS INC. (ALMS) from its SEC filings: 2025 revenue $24.1 million, net margin -1012%, free cash flow -$370.2 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Revenue (2025) | $24.1 million |
| Net income | -$243.3 million |
| Net margin | -1011.7% |
| Free cash flow | -$370.2 million |
| Diluted EPS | $-2.86 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | -38% |
| Cash | $63.7 million |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.